DEFINITIVE CONTRACT
Active75F40126C00154
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$600K
obligated · signed 2 months ago
EO 14398 - (BAA# FY26C1CP17) RELEASE MECHANISMS OF ORAL MR PRODUCTS: DISSOLUTION METHOD DEVELOPMENT AND MECHANISTIC INSIGHTS
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2028
with all options
Loading status
Estimated start: Sep 29, 2027
UNIVERSITY OF CONNECTICUT
Contract 75F40126C00154
UEI
WNTPS995QBM7
Parent Company
UNIVERSITY OF CONNECTICUT
Capabilities & Certifications
Headquarters Location
Congressional District: 02
Current Obligation
$599,999
Base + Exercised Options
$599,999
Total Ceiling Value
$599,999
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
Place of Performance
Congressional District: 02
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.